Leiomyosarcoma of the inferior vena cava (IVC) is a rare malignant tumour of smooth muscle origin. It commonly presents with non-specific symptoms including abdominal pain, distention, and lower extremity edema. Surgical resection with macroscopically clear margins is the only potential curative treatment for the disease. Here we present the case of a previously healthy 38-year-old woman with a subacute one-month increase of a four-year slowly progressive right sided abdominal pain and back pain. Imaging revealed a 14.5x12x15cm mass in the right hepatic lobe causing mass effect on adjacent abdominal and retroperitoneal organs, and involving the retrohepatic IVC. En-bloc resection of the right hemi-liver, most of segment four, the caudate lobe, and approximately a 10 cm section of the retrohepatic IVC, along with IVC reconstruction, was performed. Histologic examination revealed the diagnosis of a high grade leiomyosarcoma.
Crohn’s disease (CD) is a chronic inflammatory bowel disease characterized by transmural inflammation occurring anywhere along the gastrointestinal tract. Intestinal malrotation is an embryological error resulting in an abnormal gut anatomy. Although these two conditions rarely present concurrently, it is important to identify their presence, which is challenging due to their nonspecific, overlapping symptoms. Here, we present two patients with concomitant CD and intestinal malrotation. Both patients’ conditions required surgical intervention, which was complicated due to their unique anatomy. Clinicians should be aware of the potential pit-falls that may occur due to the anomaly and thus require a full understanding of the anatomy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.